Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer

These findings suggest that leveraging naturally occurring commensal-derived antigens through OMPs could significantly remodel the tumor immune landscape, offering guidance for a promising strategy for cancer peptide-based immunotherapies.

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-02-01
DOI
https://doi.org/10.1136/jitc-2024-010192
Citations
3
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
2.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer

Chloé Ventujol, Alice Talpin, Christophe Bonny, Cécile Gouttefangeas et al.
3 citations
Journal for ImmunoTherapy of Cancer
Immunotherapy and Immune Responses
2.39
article

Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer

Chloé Ventujol, Alice Talpin, Christophe Bonny, Cécile Gouttefangeas, María Vieito, Coline Billerey, Cheyenne Calderon, Marine Malfroy, Iris Mildenberger, Michael C. Burger, Catia Pereira Oliveira, Julie Noguerol, Laura Boullerot, Alexandrine Garnier, Karl Laviolette, Guillaume Kulakowski, François Ghiringhelli, Olivier Joffre, Camille Gaal, Jérôme Kervevan, Laurent Chêne, Francesco Strozzi, David A. Reardon, Olivier Adotévi, Agostina Stradella, Ulrich Herrlinger, Lucie Aubergeon, Ludivine Amable, João G. Magalhães, Tifanny Mersceman, Wolfgang Wick, Jean-Marie Carpier, Ghazaleh Tabatabai, Diana Bachrouche, Ahmed Idbaïh, Ana Maia, Jennifer Martinez, Grégoire Chevalier, Léa Bernard, Michaël Bonnet, Amandine Manteau
article en
3 citations

Abstract

These findings suggest that leveraging naturally occurring commensal-derived antigens through OMPs could significantly remodel the tumor immune landscape, offering guidance for a promising strategy for cancer peptide-based immunotherapies.

Journal for ImmunoTherapy of CancerVol. 13(2)
Goethe University Frankfurt (DE), Centre National de la Recherche Scientifique (FR), Université Toulouse III - Paul Sabatier (FR), Inserm (FR), University of Mannheim (DE), Université Fédérale de Toulouse Midi-Pyrénées (FR), German Cancer Research Center (DE), Heidelberg University (DE), University Hospital Bonn (DE), University Hospital Heidelberg (DE), Sorbonne Université (FR), Centre Georges François Leclerc (FR), Assistance Publique – Hôpitaux de Paris (FR), Toulouse Mathematics Institute (FR), Enterome (France) (FR), Dana-Farber Cancer Institute (US), Vall d'Hebron Hospital Universitari (ES), University Hospital Frankfurt (DE), Hertie Institute for Clinical Brain Research (DE), Duran i Reynals Hospital (ES), University of Tübingen (DE), Université de Franche-Comté (FR)
Université de Lausanne, Sorbonne Université
Good health and well-being
Openalex Percentile: Top 13%
Immunotherapy and Immune Responses
2.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.